Morphine produces immunosuppressive effects in nonhuman primates at the proteomic and cellular levels

Molecular and Cellular Proteomics

Volumn 11, Issue 9, 2012, Pages 605-618

  Brown, Joseph N ^a   Ortiz, Gabriel M ^b   Angel, Thomas E ^a   Jacobs, Jon M ^a   Gritsenko, Marina ^a   Chan, Eric Y ^c   Purdy, David E ^c   Murnane, Robert D ^c   Larsen, Kay ^c   Palermo, Robert E ^c   Shukla, Anil K ^a   Clauss, Theresa R ^a   Katze, Michael G ^c   McCune, Joseph M ^c   Smith, Richard D ^a  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; MORPHINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CELL MATURATION; CELL STRUCTURE; CELLULAR IMMUNITY; CEREBROSPINAL FLUID; CHLOROCEBUS; COLON; CONTROLLED STUDY; ENERGY METABOLISM; IMMUNE DEFICIENCY; IN VIVO STUDY; LENTIVIRUS INFECTION; LYMPH NODE; LYMPHOCYTE COUNT; MACACA; NATURAL KILLER CELL; NEUTROPHIL COUNT; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEOMICS; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; CERCOPITHECUS AETHIOPS; COLON; CYTOKINES; ENERGY METABOLISM; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; KI-67 ANTIGEN; KILLER CELLS, NATURAL; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MACACA NEMESTRINA; MORPHINE; NEUTROPHILS; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION; SUBSTANCE-RELATED DISORDERS; T-LYMPHOCYTES;

ANIMALIA; CERCOPITHECUS AETHIOPS; MACACA NEMESTRINA; PRIMATES;

EID: 84865769985     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.016121     Document Type: Article

References (81)

1. CDC (2003) HIV diagnoses among injection-drug users in states with HIV surveillance-25 states, 1994-2000. MMWR Morb. Mortal. Wkly. Rep. 52, 634-636
2. CDC (2006) Methamphetamine use and HIV risk behaviors among heterosexual men-preliminary results from five northern California counties, December 2001-November 2003. MMWR Morb. Mortal. Wkly. Rep. 55, 273-277
3. Szabo, I., Rojavin, M., Bussiere, J. L., Eisenstein, T. K., Adler, M. W., and Rogers, T. J. (1993) Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. J. Pharmacol. Exp. Ther. 267, 703-706
4. Messmer, D., Hatsukari, I., Hitosugi, N., Schmidt-Wolf, I. G., and Singhal, P. C. (2006) Morphine reciprocally regulates IL-10 and IL-12 production by monocyte-derived human dendritic cells and enhances T cell activation. Mol. Med. 12, 284-290
5. Ho, W. Z., Guo, C. J., Yuan, C. S., Douglas, S. D., and Moss, J. (2003) Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytes. J. Pharmacol. Exp.Ther. 307, 1158-1162
6. Bussiere, J. L., Adler, M. W., Rogers, T. J., and Eisenstein, T. K. (1993) Effects of in vivo morphine treatment on antibody responses in C57BL/6 bgJ/bgJ (beige) mice. Life Sci. 52, PL43-48
7. Gomez-Flores, R., and Weber, R. J. (2000) Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray. Immunopharmacology48, 145-156
8. Carrigan, K. A., Saurer, T. B., Ijames, S. G., and Lysle, D. T. (2004) Buprenorphine produces naltrexone reversible alterations of immune status. Int. Immunopharmacol. 4, 419-428
9. Carpenter, G. W., and Carr, D. J. (1995) Pretreatment with beta-funaltrexamine blocks morphine-mediated suppression of CTL activity in alloimmunized mice. Immunopharmacology 29, 129-140
10. Sacerdote, P., Franchi, S., Gerra, G., Leccese, V., Panerai, A. E., and Somaini, L. (2008) Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function. Brain Behav. Immun.22, 606-613
11. Tubaro, E., Avico, U., Santiangeli, C., Zuccaro, P., Cavallo, G., Pacifici, R., Croce, C., and Borelli, G. (1985) Morphine and methadone impact on human phagocytic physiology. Int. J. Immunopharmacol. 7, 865-874
12. Zajicova, A., Wilczek, H., and Holan, V. (2004) The alterations of immunological reactivity in heroin addicts and their normalization in patients maintained on methadone. Folia Biol. 50, 24-28
13. Hutchinson, M. R., and Somogyi, A. A. (2004) (S)-(+)-methadone is more immunosuppressive than the potent analgesic (R)-(-)-methadone. Int.Immunopharmacol. 4, 1525-1530
14. Sacerdote, P. (2006) Opioids and the immune system. Palliat. Med. 20, s9-15
15. D'Elia, M., Patenaude, J., Hamelin, C., Garrel, D. R., and Bernier, J. (2003) No detrimental effect from chronic exposure to buprenorphine on corti-costeroid-binding globulin and corticosensitive immune parameters. Clin. Immunol. 109, 179-187
16. Van Loveren, H., Gianotten, N., Hendriksen, C. F., Schuurman, H. J., and Van der Laan, J. W. (1994) Assessment of immunotoxicity of buprenorphine. Lab. Anim. 28, 355-363
17. Marone, G., Stellato, C., Mastronardi, P., and Mazzarella, B. (1993) Mechanisms of activation of human mast cells and basophils by general anesthetic drugs. Ann. Fr. Anesth. Reanim. 12, 116-125
18. McLachlan, C., Crofts, N., Wodak, A., and Crowe, S. (1993) The effects of methadone on immune function among injecting drug users: a review. Addiction 88, 257-263
19. Bierczynska-Krzysik, A., Bonar, E., Drabik, A., Noga, M., Suder, P., Dylag, T., Dubin, A., Kotlinska, J., and Silberring, J. (2006) Rat brain proteome in morphine dependence. Neurochem. Int. 49, 401-406
20. Bierczynska-Krzysik, A., Pradeep John, J. P., Silberring, J., Kotlinska, J., Dylag, T., Cabatic, M., and Lubec, G. (2006) Proteomic analysis of rat cerebral cortex, hippocampus and striatum after exposure to morphine. Int. J. Mol. Med. 18, 775-784
21. Li, K. W., Jimenez, C. R., van der Schors, R. C., Hornshaw, M. P., Schoffelmeer, A. N., and Smit, A. B. (2006) Intermittent administration of morphine alters protein expression in rat nucleus accumbens. Proteomics6, 2003-2008
22. Kim, S. Y., Chudapongse, N., Lee, S. M., Levin, M. C., Oh, J. T., Park, H. J., and Ho, I. K. (2005) Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains. Brain Res. Mol. Brain Res. 133, 58-70
23. Chen, X. L., Lu, G., Gong, Y. X., Zhao, L. C., Chen, J., Chi, Z. Q., Yang, Y. M., Chen, Z., Li, Q. L., and Liu, J. G. (2007) Expression changes of hippocampal energy metabolism enzymes contribute to behavioural abnormalities during chronic morphine treatment. Cell Res. 17, 689-700
24. Shui, H. A., Ho, S. T., Wang, J. J., Wu, C. C., Lin, C. H., Tao, Y. X., and Liaw, W. J. (2007) Proteomic analysis of spinal protein expression in rats exposed to repeated intrathecal morphine injection. Proteomics 7, 796-803
25. Li, Q., Zhao, X., Zhong, L. J., Yang, H. Y., Wang, Q., and Pu, X. P. (2009) Effects of chronic morphine treatment on protein expression in rat dorsal root ganglia. Eur. J. Pharmacol. 612, 21-28
26. Yang, L., Sun, Z. S., and Zhu, Y. P. (2007) Proteomic analysis of rat prefrontal cortex in three phases of morphine-induced conditioned place preference. J. Proteome Res. 6, 2239-2247
27. Morón, J. A., Abul-Husn, N. S., Rozenfeld, R., Dolios, G., Wang, R., and Devi, L. A. (2007) Morphine administration alters the profile of hippocampal postsynaptic density-associated proteins: a proteomics study focusing on endocytic proteins. Mol. Cell. Proteomics 6, 29-42
28. Prokai, L., Zharikova, A. D., and Stevens, S. M., Jr. (2005) Effect of chronic morphine exposure on the synaptic plasma-membrane subproteome of rats: a quantitative protein profiling study based on isotope-coded affinity tags and liquid chromatography/mass spectrometry. J. Mass Spectrom.40, 169-175
29. Moulédous, L., Neasta, J., Uttenweiler-Joseph, S., Stella, A., Matondo, M., Corbani, M., Monsarrat, B., and Meunier, J. C. (2005) Long-term morphine treatment enhances proteasome-dependent degradation of G beta in human neuroblastoma SH-SY5Y cells: correlation with onset of adenylate cyclase sensitization. Mol. Pharmacol. 68, 467-476
30. Neasta, J., Uttenweiler-Joseph, S., Chaoui, K., Monsarrat, B., Meunier, J. C., and Moulédous, L. (2006) Effect of long-term exposure of SH-SY5Y cells to morphine: a whole cell proteomic analysis. Proteome Sci. 4, 23
31. Bodzon-Kulakowska, A., Bierczynska-Krzysik, A., Drabik, A., Noga, M., Kraj, A., Suder, P., and Silberring, J. (2005) Morphinome-proteome of the nervous system after morphine treatment. Amino Acids 28, 13-19
32. Suder, P., Bodzon-Kulakowska, A., Mak, P., Bierczynska-Krzysik, A., Daszykowski, M., Walczak, B., Lubec, G., Kotlinska, J. H., and Silberring, J. (2009) The proteomic analysis of primary cortical astrocyte cell culture after morphine administration. J. Proteome Res. 8, 4633-4640
33. Xu, H., Wang, X., Zimmerman, D., Boja, E. S., Wang, J., Bilsky, E. J., and Rothman, R. B. (2005) Chronic morphine up-regulates G alpha12 and cytoskeletal proteins in Chinese hamster ovary cells expressing the cloned mu opioid receptor. J. Pharmacol Exp. Ther. 315, 248-255
34. Bodzon-Kulakowska, A., Kulakowski, K., Drabik, A., Moszczynski, A., Silberring, J., and Suder, P. (2011) Morphinome-a meta-analysis applied to proteomics studies in morphine dependence. Proteomics 11, 5-21
35. Kruisbeek, A. M. (2001) Isolation of mouse mononuclear cells. Curr. Protoc.Immunol. Chapter 3, Unit 3 1
36. Marginean, I., Kelly, R. T., Moore, R. J., Prior, D. C., LaMarche, B. L., Tang, K., and Smith, R. D. (2009) Selection of the optimum electrospray voltage for gradient elution LC-MS measurements. J. Am. Soc. Mass. Spectrom.20, 682-688
37. Kelly, R. T., Page, J. S., Zhao, R., Qian, W. J., Mottaz, H. M., Tang, K., and Smith, R. D. (2008) Capillary-based multi nanoelectrospray emitters: improvements in ion transmission efficiency and implementation with capillary reversed-phase LC-ESI-MS. Anal. Chem. 80, 143-149
38. Page, J. S., Kelly, R. T., Tang, K., and Smith, R. D. (2007) Ionization and transmission efficiency in an electrospray ionization-mass spectrometry interface. J. Am. Soc. Mass Spectrom. 18, 1582-1590
39. Gibbs, R. A., Rogers, J., Katze, M. G., Bumgarner, R., Weinstock, G. M., Mardis, E. R., Remington, K. A., Strausberg, R. L., Venter, J. C., Wilson, R. K., Batzer, M. A., Bustamante, C. D., Eichler, E. E., Hahn, M. W., Hardison, R. C., Makova, K. D., Miller, W., Milosavljevic, A., Palermo, R. E., Siepel, A., Sikela, J. M., Attaway, T., Bell, S., Bernard, K. E., Buhay, C. J., Chandrabose, M. N., Dao, M., Davis, C., Delehaunty, K. D., Ding, Y., Dinh, H. H., Dugan-Rocha, S., Fulton, L. A., Gabisi, R. A., Garner, T. T., Godfrey, J., Hawes, A. C., Hernandez, J., Hines, S., Holder, M., Hume, J., Jhangiani, S. N., Joshi, V., Khan, Z. M., Kirkness, E. F., Cree, A., Fowler, R. G., Lee, S., Lewis, L. R., Li, Z., Liu, Y. S., Moore, S. M., Muzny, D., Nazareth, L. V., Ngo, D. N., Okwuonu, G. O., Pai, G., Parker, D., Paul, H. A., Pfannkoch, C., Pohl, C. S., Rogers, Y. H., Ruiz, S. J., Sabo, A., Santibanez, J., Schneider, B. W., Smith, S. M., Sodergren, E., Svatek, A. F., Utterback, T. R., Vattathil, S., Warren, W., White, C. S., Chinwalla, A. T., Feng, Y., Halpern, A. L., Hillier, L. W., Huang, X., Minx, P., Nelson, J. O., Pepin, K. H., Qin, X., Sutton, G. G., Venter, E., Walenz, B. P., Wallis, J. W., Worley, K. C., Yang, S. P., Jones, S. M., Marra, M. A., Rocchi, M., Schein, J. E., Baertsch, R., Clarke, L., Csuros, M., Glasscock, J., Harris, R. A., Havlak, P., Jackson, A. R., Jiang, H., Liu, Y., Messina, D. N., Shen, Y., Song, H. X., Wylie, T., Zhang, L., Birney, E., Han, K., Konkel, M. K., Lee, J., Smit, A. F., Ullmer, B., Wang, H., Xing, J., Burhans, R., Cheng, Z., Karro, J. E., Ma, J., Raney, B., She, X., Cox, M. J., Demuth, J. P., Dumas, L. J., Han, S. G., Hopkins, J., Karimpour-Fard, A., Kim, Y. H., Pollack, J. R., Vinar, T., Addo-Quaye, C., Degenhardt, J., Denby, A., Hubisz, M. J., Indap, A., Kosiol, C., Lahn, B. T., Lawson, H. A., Marklein, A., Nielsen, R., Vallender, E. J., Clark, A. G., Ferguson, B., Hernandez, R. D., Hirani, K., Kehrer-Sawatzki, H., Kolb, J., Patil, S., Pu, L. L., Ren, Y., Smith, D. G., Wheeler, D. A., Schenck, I., Ball, E. V., Chen, R., Cooper, D. N., Giardine, B., Hsu, F., Kent, W. J., Lesk, A., Nelson, D. L., O'Brien W, E., Prufer, K., Stenson, P. D., Wallace, J. C., Ke, H., Liu, X. M., Wang, P., Xiang, A. P., Yang, F., Barber, G. P., Haussler, D., Karolchik, D., Kern, A. D., Kuhn, R. M., Smith, K. E., and Zwieg, A. S. (2007) Evolutionary and biomedical insights from the rhesus macaque genome. Science 316, 222-234
40. Chen, Y., Cunningham, F., Rios, D., McLaren, W. M., Smith, J., Pritchard, B., Spudich, G. M., Brent, S., Kulesha, E., Marin-Garcia, P., Smedley, D., Birney, E., and Flicek, P. (2010) Ensembl variation resources. BMCGenomics 11, 293
41. Berglund, A. C., Sjoülund, E., Ostlund, G., and Sonnhammer, E. L. (2008) InParanoid 6: eukaryotic ortholog clusters with inparalogs. Nucleic AcidsRes. 36, D263-266
42. O'Brien, K. P., Remm, M., and Sonnhammer, E. L. (2005) Inparanoid: a comprehensive database of eukaryotic orthologs. Nucleic Acids Res. 33, D476-480
43. Remm, M., Storm, C. E., and Sonnhammer, E. L. (2001) Automatic clustering of orthologs and in-paralogs from pairwise species comparisons. J. Mol. Biol. 314, 1041-1052
44. Brown, J. N., Palermo, R. E., Baskin, C. R., Gritsenko, M., Sabourin, P. J., Long, J. P., Sabourin, C. L., Bielefeldt-Ohmann, H., Garcia-Sastre, A., Albrecht, R., Tumpey, T. M., Jacobs, J. M., Smith, R. D., and Katze, M. G. (2010) Macaque Proteome Response to Highly Pathogenic Avian Influenza and 1918 Reassortant Influenza Virus Infections. J. Virol. 84, 12058-12068
45. Brown, J. N., Estep, R. D., Lopez-Ferrer, D., Brewer, H. M., Clauss, T. R., Manes, N. P., O'Connor, M., Li, H., Adkins, J. N., Wong, S. W., and Smith, R. D. (2010) Characterization of Macaque Pulmonary Fluid Proteome during Monkeypox Infection: Dynamics of Host Response. Mol.Cell. Proteomics 9, 2760-2771
46. Zimmer, J. S., Monroe, M. E., Qian, W. J., and Smith, R. D. (2006) Advances in proteomics data analysis and display using an accurate mass and time tag approach. Mass Spectrom. Rev. 25, 450-482
47. Stanley, J. R., Adkins, J. N., Slysz, G. W., Monroe, M. E., Purvine, S. O., Karpievitch, Y. V., Anderson, G. A., Smith, R. D., and Dabney, A. R. (2011) A statistical method for assessing Peptide identification confidence in accurate mass and time tag proteomics. Anal. Chem. 83, 6135-6140
48. Jaitly, N., Monroe, M. E., Petyuk, V. A., Clauss, T. R., Adkins, J. N., and Smith, R. D. (2006) Robust algorithm for alignment of liquid chromatography-mass spectrometry analyses in an accurate mass and time tag data analysis pipeline. Anal. Chem. 78, 7397-7409
49. Kiebel, G. R., Auberry, K. J., Jaitly, N., Clark, D. A., Monroe, M. E., Peterson, E. S., Tolić, N., Anderson, G. A., and Smith, R. D. (2006) PRISM: a data management system for high-throughput proteomics. Proteomics 6, 1783-1790
50. Monroe, M. E., Tolić, N., Jaitly, N., Shaw, J. L., Adkins, J. N., and Smith, R. D. (2007) VIPER: an advanced software package to support high-throughput LC-MS peptide identification. Bioinformatics 23, 2021-2023
51. Monroe, M. E., Shaw, J. L., Daly, D. S., Adkins, J. N., and Smith, R. D. (2008) MASIC: a software program for fast quantitation and flexible visualization of chromatographic profiles from detected LC-MS(/MS) features. Comput. Biol. Chem. 32, 215-217
52. Petritis, K., Kangas, L. J., Yan, B., Monroe, M. E., Strittmatter, E. F., Qian, W. J., Adkins, J. N., Moore, R. J., Xu, Y., Lipton, M. S., Camp, D. G., 2nd, and Smith, R. D. (2006) Improved peptide elution time prediction for reversed-phase liquid chromatography-MS by incorporating peptide sequence information. Anal. Chem. 78, 5026-5039
53. Matzke, M. M., Waters, K. M., Metz, T. O., Jacobs, J. M., Sims, A. C., Baric, R. S., Pounds, J. G., and Webb-Robertson, B. J. (2011) Improved quality control processing of peptide-centric LC-MS proteomics data. Bioinformatics27, 2866-2872
54. Karpievitch, Y., Stanley, J., Taverner, T., Huang, J., Adkins, J. N., Ansong, C., Heffron, F., Metz, T. O., Qian, W. J., Yoon, H., Smith, R. D., and Dabney, A. R. (2009) A statistical framework for protein quantitation in bottom-up MS-based proteomics. Bioinformatics 25, 2028-2034
55. Benjamini, Y., and Hochberg, Y. (1995) Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing. J. Roy.Stat. Soc. 57, 289-300
56. Dennis, G., Jr., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., and Lempicki, R. A. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4, P3
57. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57
58. Thomas, P. D., Kejariwal, A., Campbell, M. J., Mi, H., Diemer, K., Guo, N., Ladunga, I., Ulitsky-Lazareva, B., Muruganujan, A., Rabkin, S., Vandergriff, J. A., and Doremieux, O. (2003) PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res. 31, 334-341
59. Durinck, S., Moreau, Y., Kasprzyk, A., Davis, S., De Moor, B., Brazma, A., and Huber, W. (2005) BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics 21, 3439-3440
60. Dodge, P. W., and Takemori, A. E. (1969) Effect of morphine on cerebral glycolytic intermediates and enzymes of rats in vitro. Biochem. Pharmacol. 18, 1873-1882
61. Gragera, R. R., de Miguel, E., Muñiz, E., Arenas-Díaz, G., Alonso, M. J., Gomez de Segura, I. A., and Martínez-Rodriguez, R. (1995) L-aspartate aminotransferase and L-asparaginase in rat lymph node: a histoenzymological and immunohistochemical study. Eur. J. Histochem. 39, 195-200
62. Prager, M. D., and Derr, I. (1971) Metabolism of asparagine, aspartate, glutamine, and glutamate in lymphoid tissue: basis for immunosuppression by L-asparaginase. J. Immunol. 106, 975-979
63. Cui, Y., Ying, Y., van Hasselt, A., Ng, K. M., Yu, J., Zhang, Q., Jin, J., Liu, D., Rhim, J. S., Rha, S. Y., Loyo, M., Chan, A. T., Srivastava, G., Tsao, G. S., Sellar, G. C., Sung, J. J., Sidransky, D., and Tao, Q. (2008) OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. PLoS ONE 3, e2990
64. Ishiguro, H., Liu, Q. R., Gong, J. P., Hall, F. S., Ujike, H., Morales, M., Sakurai, T., Grumet, M., and Uhl, G. R. (2006) NrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout mice. Neuropsychopharmacology31, 572-584
65. Sato, S., Cerny, R. L., Buescher, J. L., and Ikezu, T. (2006) Tau-tubulin kinase 1 (TTBK1), a neuron-specific tau kinase candidate, is involved in tau phosphorylation and aggregation. J. Neurochem. 98, 1573-1584
66. Edener, U., Kurth, I., Meiner, A., Hoffmann, F., Hubner, C. A., Bernard, V., Gillessen-Kaesbach, G., and Zuühlke, C. (2009) Missense exchanges in the TTBK2 gene mutated in SCA11. J. Neurol. 256, 1856-1859
67. Ferenczi, S., Núñez, C., Pintér-Kuübler, B., Foüldes, A., Martín, F., Márkus, V. L., Milanés, M. V., and Kovács, K. J. (2010) Changes in metabolicrelated variables during chronic morphine treatment. Neurochem. Int. 57, 323-330
68. Saurer, T. B., Ijames, S. G., and Lysle, D. T. (2006) Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity. J. Neuroimmunol. 177, 18-26
69. Lipovsky, M. M., Gekker, G., Hu, S., Hoepelman, A. I., and Peterson, P. K. (1998) Morphine enhances complement receptor-mediated phagocytosis of Cryptococcus neoformans by human microglia. Clin. Immunol.Immunopathol. 87, 163-167
70. Welters, I. D., Menzebach, A., Goumon, Y., Langefeld, T. W., Teschemacher, H., Hempelmann, G., and Stefano, G. B. (2000) Morphine suppresses complement receptor expression, phagocytosis, and respiratory burst in neutrophils by a nitric oxide and mu(3) opiate receptor-dependent mechanism. J. Neuroimmunol. 111, 139-145
71. Rivera-Amill, V., Silverstein, P. S., Noel, R. J., Jr., Kumar, S., and Kumar, A. (2010) Morphine and rapid disease progression in nonhuman primate model of AIDS: inverse correlation between disease progression and virus evolution. J. Neuroimmune Pharmacol. 5, 122-132
72. Carr, D. J., and France, C. P. (1993) Immune alterations in morphine-treated rhesus monkeys. J. Pharmacol. Exp. Ther. 267, 9-15
73. Bokhari, S. M., Hegde, R., Callen, S., Yao, H., Adany, I., Li, Q., Li, Z., Pinson, D., Yeh, H. W., Cheney, P. D., and Buch, S. (2011) Morphine Potentiates Neuropathogenesis of SIV Infection in Rhesus Macaques. J. Neuroimmune Pharmacol. 6, 626-639
74. Good, D. M., Thongboonkerd, V., Novak, J., Bascands, J. L., Schanstra, J. P., Coon, J. J., Dominiczak, A., and Mischak, H. (2007) Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J. Proteome Res. 6, 4549-4555
75. Odunayo, A., Dodam, J. R., Kerl, M. E., and DeClue, A. E. (2010) Immunomodulatory effects of opioids. J. Vet. Emerg. Crit. Care 20, 376-385
76. Fruühbeck, G., Gómez-Ambrosi, J., Muruzábal, F. J., and Burrell, M. A. (2001) The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am. J. Physiol. EndocrinolMetab. 280, E827-847
77. Fox, C. J., Hammerman, P. S., and Thompson, C. B. (2005) Fuel feeds function: energy metabolism and the T-cell response. Nat. Rev. Immunol.5, 844-852
78. Guzmán, M., and Sánchez, C. (1999) Effects of cannabinoids on energy metabolism. Life Sci. 65, 657-664
79. Polak, J. M., Bloom, S. R., Sullivan, S. N., Facer, P., and Pearse, A. G. (1977) Enkephalin-like immunoreactivity in the human gastrointestinal tract. Lancet 1, 972-974
80. Frantzides, C. T., Condon, R. E., Schulte, W. J., and Cowles, V. (1990) Effects of morphine on colonic myoelectric and motor activity in subhuman primates. Am. J. Physiol. 258, G247-252
81. DeHaven-Hudkins, D. L., DeHaven, R. N., Little, P. J., and Techner, L. M. (2008) The involvement of the mu-opioid receptor in gastrointestinal pathophysiology: therapeutic opportunities for antagonism at this receptor. Pharmacol. Ther. 117, 162-187